Hikma Pharmaceuticals Plc Stock Forecast
Hikma Pharmaceuticals Plc stock price up 0.0550% on Tuesday
(Updated on Apr 23, 2024)
The Hikma Pharmaceuticals Plc stock price gained 0.0550% on the last trading day (Tuesday, 23rd Apr 2024), rising from £1,818.00 to £1,819.00. It has now gained 4 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 1.05% from a day low at £1,813.00 to a day high of £1,832.00. The price has risen in 6 of the last 10 days and is up by 0.11% over the past 2 weeks. Volume fell on the last day by -44 thousand shares and in total, 471 thousand shares were bought and sold for approximately £856.32 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -6.97% during the next 3 months and, with a 90% probability hold a price between £1,641.50 and £1,846.47 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
HIK.L Signals & Forecast
There are mixed signals in the stock today. The Hikma Pharmaceuticals Plc stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at £1,858.83. On a fall, the stock will find some support from the short-term average at £1,798.86. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). A buy signal was issued from a pivot bottom point on Wednesday, April 17, 2024, and so far it has risen 2.54%. Further rise is indicated until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.
Support, Risk & Stop-loss for Hikma Pharmaceuticals Plc stock
Hikma Pharmaceuticals Plc finds support from accumulated volume at £1,817.00 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved £19.00 between high and low, or 1.05%. For the last week, the stock has had daily average volatility of 1.57%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (HIK.L) For The Upcoming Trading Day Of Wednesday 24th
For the upcoming trading day on Wednesday, 24th we expect Hikma Pharmaceuticals Plc to open at £1,821.33, and during the day (based on 14 day Average True Range), to move between £1,780.80 and £1,857.20, which gives a possible trading interval of +/-£38.20 (+/-2.10%) up or down from last closing price. If Hikma Pharmaceuticals Plc takes out the full calculated possible swing range there will be an estimated 4.20% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at £1,817.00 (0.11%) than the resistance at £1,939.50 (6.62%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Hikma Pharmaceuticals Plc stock A Buy?
Hikma Pharmaceuticals Plc holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.
Current score: -2.097 Sell Candidate Unchanged
Predicted Opening Price for Hikma Pharmaceuticals Plc of Wednesday, April 24, 2024
| Fair opening price April 24, 2024 | Current price |
|---|---|
| £1,821.33 ( 0.128%) | £1,819.00 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for HIK.L
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 1,840.33 | 1.17 % | |
| R2 | 1,833.08 | 0.774 % | ||
| R1 | 1,828.59 | 0.527 % | ||
| Current price: | 1,819.00 | |||
| Support | S1 | 1,814.08 | -0.271 % | |
| S2 | 1,809.59 | -0.517 % | ||
| S3 | 1,802.33 | -0.92 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 2,083.00 | 14.51 % | |
| R2 | 1,994.00 | 9.62 % | ||
| R1 | 1,939.50 | 6.62 % | ||
| Current price | 1,819.00 | |||
| Support | S1 | 1,817.00 | -0.110% | |
| S2 | 1,789.00 | -1.65% | ||
| S3 | 1,786.00 | -1.81% |
HIK Dividend Payout History
| # | Ex-Date | Pay Date | Amount | Yield | |
|---|---|---|---|---|---|
| 1 | Mar 21, 2024 | Mar 21, 2024 | May 03, 2024 | £37.07 | 2.04% |
| 2 | Feb 23, 2023 | Mar 23, 2023 | May 05, 2023 | £29.52 | 1.58% |
| 3 | Aug 04, 2022 | Aug 18, 2022 | Sep 19, 2022 | £16.00 | 1.28% |
| 4 | Feb 24, 2022 | Mar 17, 2022 | Apr 28, 2022 | £26.00 | 1.28% |
| 5 | Aug 06, 2021 | Aug 19, 2021 | Sep 20, 2021 | £13.00 | 0.545% |
FAQ
Click here for our free guide on how to buy Hikma Pharmaceuticals Plc Stock.
